The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: ALDH2 Mutation in Taiwanese Head and Neck Cancer
Official Title: Correlation Between Radiation Dermatitis/Mucositis and ALDH2 Mutation in Taiwanese Head and Neck Cancer
Study ID: NCT02761408
Brief Summary: The purpose of this study is to evaluate the effect of ALDH2 mutation in radiation associating dermatitis or mucositis in head and neck cancer patients who accept chemoradiation therapy
Detailed Description: * One-site audit. The enrolled subject is confirmed by PIs ◦◦Source data is compared to external data sources medical records, either paper or electronic case report forms. * NCI CTCAE v5.0 for AE records * Patient recruitment according to inclusion criteria: 1. Newly diagnosed locally head and neck squamous cell carcinoma; 2. Apply for primary chemoradiation or adjuvant chemoradiation; 3. Signed informed consent * Sample size assessment: 60 subjects will be included in one year for total 120 subjects * Missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results * Fisher's exact test is for category comparison. Kaplan-Meier analysis is for survival analysis. AE grades will be analyzed according to NCI guideline. Two-side p \< 0.05 is suggested significant.
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Cancer Center, Taipei Veterans General Hospital, Taipei, , Taiwan
Name: Ling-Wei Wang, MD
Affiliation: Cancer Center, Taipei Veterans General Hospital
Role: PRINCIPAL_INVESTIGATOR